Last reviewed · How we verify

Human immunoglobulin — Competitive Intelligence Brief

Human immunoglobulin (Human immunoglobulin) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Human Immunoglobulin G [EPC].

marketed Human Immunoglobulin G [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

Human immunoglobulin (Human immunoglobulin) — Centre Hospitalier St Anne.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Human immunoglobulin TARGET Human immunoglobulin Centre Hospitalier St Anne marketed Human Immunoglobulin G [EPC]
HUMAN IMMUNOGLOBULIN G HUMAN IMMUNOGLOBULIN G marketed Human Immunoglobulin G [EPC] 2006-01-01
Botulinum neurotoxin Botulinum neurotoxin University of Miami marketed Human Immunoglobulin G [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Human Immunoglobulin G [EPC] class)

  1. · 1 drug in this class
  2. Centre Hospitalier St Anne · 1 drug in this class
  3. University of Miami · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Human immunoglobulin — Competitive Intelligence Brief. https://druglandscape.com/ci/human-immunoglobulin. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: